Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Current Taxes (2023 - 2025)

Spero Therapeutics (SPRO) has disclosed Current Taxes for 3 consecutive years, with $163000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Taxes rose 68.04% year-over-year to $163000.0, compared with a TTM value of $163000.0 through Sep 2025, up 68.04%, and an annual FY2024 reading of $174000.0, down 55.04% over the prior year.
  • Current Taxes was $163000.0 for Q3 2025 at Spero Therapeutics, roughly flat from $163000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $2.2 million in Q3 2023 and bottomed at $97000.0 in Q3 2024.
  • Average Current Taxes over 3 years is $460333.3, with a median of $174000.0 recorded in 2024.
  • The sharpest move saw Current Taxes crashed 95.61% in 2024, then soared 68.04% in 2025.
  • Year by year, Current Taxes stood at $387000.0 in 2023, then plummeted by 55.04% to $174000.0 in 2024, then fell by 6.32% to $163000.0 in 2025.
  • Business Quant data shows Current Taxes for SPRO at $163000.0 in Q3 2025, $163000.0 in Q2 2025, and $174000.0 in Q1 2025.